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Abstract
In vascular smooth muscle cells (VSMCs) integrin-mediated adhesion to extracellular
matrix (ECM) proteins play important roles in sustaining vascular tone and resistance.
The main goal of this study was to determine whether VSMCs adhesion to type I collagen
(COL-I) was altered in parallel with the changes in the VSMCs contractile state induced by
vasoconstrictors and vasodilators. VSMCs were isolated from rat cremaster skeletal muscle
arterioles and maintained in primary culture without passage. Cell adhesion and cell E-mod-
ulus were assessed using atomic force microscopy (AFM) by repetitive nano-indentation of
the AFM probe on the cell surface at 0.1 Hz sampling frequency and 3200 nm Z-piezo trav-
elling distance (approach and retraction). AFM probes were tipped with a 5 μm diameter
microbead functionalized with COL-I (1mg\ml). Results showed that the vasoconstrictor an-
giotensin II (ANG-II; 10−6) significantly increased (p<0.05) VSMC E-modulus and adhesion
probability to COL-I by approximately 35% and 33%, respectively. In contrast, the vasodila-
tor adenosine (ADO; 10−4) significantly decreased (p<0.05) VSMC E-modulus and adhe-
sion probability by approximately −33% and −17%, respectively. Similarly, the NO donor
(PANOate, 10−6 M), a potent vasodilator, also significantly decreased (p<0.05) the VSMC
E-modulus and COL-I adhesion probability by −38% and −35%, respectively. These obser-
vations support the hypothesis that integrin-mediated VSMC adhesion to the ECM protein
COL-I is dynamically regulated in parallel with VSMC contractile activation. These data sug-
gest that the signal transduction pathways modulating VSMC contractile activation and re-
laxation, in addition to ECM adhesion, interact during regulation of contractile state.
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Introduction
The contractile state of vascular smooth muscle cells (VSMC) determines resistance vessel di-
ameter, which is critical to regulation of tissue blood flow and blood pressure. In addition to
the myogenic mechanism, circulating and locally derived factors can induce vasoconstriction
or dilatation to modulate vascular tone and hence diameter. As the generation of force by
VSMC involves transmission of mechanical force between the cell and the extracellular envi-
ronment, we hypothesized that changes in the contractile state of VSMC would be accompa-
nied by parallel changes in adhesion to the extracellular matrix (ECM).
Adhesion to the ECM is largely regulated by integrins that are a large family of heterodimeric
cell adhesion molecules that anchor cells to ECM and neighboring cells. Additionally, they play
key roles in many biological processes including cell motility, cytoskeleton organization, mediat-
ing the cell-cell and cell-ECM signals transduction [1–8]. Collagen (COL) is one of the major
structural components of ECMwithin vascular wall and binds to a number of different integrins
[9–12]. In this regard, integrin β1 is the most predominant integrin expressed on the surface of
VSMCs [13] and all COL binding integrins share the common β1 subunit. Fibrillar type I collagen
(COL-I) is ubiquitously expressed in all vertebrates to provide sufficient mechanical strength for
tissues and it is also directly involved in the outside-in signal transduction between the ECM and
cells [14]. In addition, integrin activation through inside-out signaling is a well-accepted mecha-
nism for modulation of integrin activation and adhesion with the ECM [15].
Changes in integrin activation and expression have been associated with a number of physi-
ological and pathological processes in the vasculature. This has been proposed to be important
for modulation of myogenic phenomena, vascular remodeling, VSMC migration, and VSMC
stiffening associated with vascular wall stiffness that occurs in aging and hypertension [16–19].
In previous studies from our laboratory we found that VSMC adhesion to fibronectin (FN) is
regulated in parallel with changes in VSMC activation in response to a vasoconstrictor (angio-
tensin II) or a vasodilator (adenosine) [4]. This raised the question as to whether this also ap-
plies to other important vascular wall ECM proteins that interact with VSMCs. Therefore, in
this study, we designed experiments to determine whether VSMC adhesion to COL-I is modu-
lated in response to changes in VSMC activation induced by a vasoconstrictor or vasodilator.
Materials and Methods
Ethics statement
Male Sprague-Dawley rats were used for this study and were maintained in accordance with
the protocol of the Guide for the Care and Use of Laboratory Animals (NIH 83-23, revised
1996). The cremaster muscles were excised from anesthetized animals using sodium pentobar-
bital (Nembutal, 100 mg/kg body weight) given by an intraperitoneal injection. Following sac-
rifice by anesthetic overdose, the rat was euthanized by thoracotomy. Death will be confirmed
by absence of both heartbeat and respiration. All the protocol was approved by the Laboratory
Animal Use Committee of the University of Missouri. (Permit number: 7416).
VSMC isolation and culture
VSMCs were enzymatically isolated from the cremaster muscle first order resistance arteriole
using a protocol published previously by our laboratory [20]. Isolated cells were placed in cul-
ture conditions in a 60 mm tissue culture dish (World Precision Instruments, Sarasota, FL) and
kept in a humidified incubator (Heraeus Instruments, Newtown, CT) with 5% CO2 at 37°C.
Cells were incubated with DMEM/F-12 (Invitrogen) supplemented with 10% FBS (Atlanta Bio-
logicals, Lawrenceville, GA), 10 mMHEPES (Sigma, St. Louis, MO), 2 mM L-glutamine, 1 mM
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sodium pyruvate, 100 U/ml penicillin, and 100 μg/ml streptomycin. For all experiments the
cells were maintained in primary culture for 3–7 days without passage. Prior to experimenta-
tion cells were rinsed with serum free media, serum starved overnight and kept in colorless
serum free medium (Invitrogen, Carlsbad, CA) without antibiotics. Except for HEPES and
FBS, all reagents were purchased from Invitrogen (Carlsbad, CA).
COL-I coating on AFM probes
A 5 μm diameter glass microbead was glued to the tip of an atomic force microscope (AFM)
probe (MLCT-O10, Santa Barbara, CA; Bruker Corp.) and the microbead tip coated with COL-I
(Sigma, St. Louis, MO). The ECM coating protocol used was described by Lehenkari and Horton
[21] and has been previously used in our laboratory [22–23]. Briefly, Polyethylene glycol (PEG,
Sigma, St. Louis, MO) was used as a linker molecule between COL-I and the microbead. The
probe was incubated with 10 mM PEG (5 min), washed with phosphate buffered saline (PBS),
and then incubated with COL-I (1 mg/ml) for 5 min followed by rinsing with PBS. Each cantile-
ver was calibrated after a given experiment using the thermal noise amplitude method of calibra-
tion [24–25]. The measured spring constants were between 10 and 20 pN/nm.
Cell adhesion and E-modulus measurement with AFM
Monitoring of biomechanical and adhesive properties of VSMCs in real-time was performed
using an Asylum AFM System (Model MFP-3D-BIO, Asylum Research, Santa Barbara, CA)
that was mounted on an inverted microscope (Model IX81, Olympus America Inc.). All AFM
measurements were conducted at room temperature (*25°C). The AFM sampling parameters
employed were 0.1 Hz sampling frequency, with an approach/retraction velocity of 320 nm/
sec, 3200 nm traveling distance for one cycle of indentation and retraction, and approximately
1000–3000 pN loading force. Cells were randomly selected and indented at a site between the
nucleus and cell margin to collect approximately 360 force curves over a 60 min experiment.
To minimize drifting, after the probe was submerged in the cell bath, the AFM system was
thermally and mechanically equilibrated for 60 min. After 60 min stabilization prior to AFM
probe indentation, the AFM drift is approximately 1–2 microns in x, y, z directions during the
one hour period needed for an experiment. In this study, the adhesion force and stiffness mea-
surement was achieved by a continuous indentation protocol at 0.1 Hz sampling frequency in
trigger mode. In trigger mode, we set the maximal indentation force exerted by AFM probe on
cell surface at a preselected value, 1000 pN for instance, the AFM probe will then automatically
retract as soon as the indentation force reaches the 1000 pN threshold during the indentation.
This also protects cells from the potential damage caused by over indentation that could lead to
cell membrane puncture. By setting this force threshold we offset the thermal drifting in the z
direction. Meanwhile, the AFM probe used in this study was 5 μm diameter bead attached to
the tip of the cantilever. This provides a contact area in excess of the 1–2 micron x-y drift and
gives us a more spatially averaged measurement with less variability compared to a sharp
tipped probe (30–50 nm tip dia). This helps to offset the drifting in x and y direction and will
not significantly affect the accuracy of the cell elasticity measurement or detection of changes
in adhesion. Each cell was subject to 10 min. of control measurements followed by 30 min.
treatment with the vasoconstrictor angiotensin II (ANG-II; 10−6), the vasodilator adenosine
(ADO; 10−4) or the nitric oxide (NO) donor (PANOate, 10−6 M).
AFM force curve analysis
The analysis of force curves was automated using a proprietary software package written in
Matlab (2014a, Mathworks). For estimating Young’s modulus (E-modulus) of the cell cortex, a
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length of the approach curve, following the initial point of contact, representing approximately
100–300 nm of AFM indentation into the VSMC, was fitted with a modified Hertz model
(Eq. 1) as illustrated in Fig. 1A [26–27].
E ¼ 3ð1 v
2Þ
4
ﬃﬃﬃﬃ
rb
p  F
d
3
2
ð1Þ
Where E is the E-modulus, F is the force exerted by the AFM probe on the cell surface, δ is the
indentation depth into the cell membrane, rb is the radius of the spherical AFM tip, and v is the
Poisson ratio for the cell. Cells were considered as a gel and the Poisson ratio v was assumed as
0.5 in this study [26]. Adhesion forces between COL-I and VSMC were determined as the
product of cantilever spring constant and the height of ruptures (cantilever deﬂection) in re-
traction force curves (Hooke’s law) as illustrated in Fig. 1B-1D. Only the ruptures with a
threshold height greater than 1.5 times of average noise ﬂuctuation within the AFM retraction
curve (normally around 18 pN) were analyzed and regarded as speciﬁc adhesions between the
Fig 1. Representative force curve recorded by AFM. (A) An example of an approach curve recorded by AFM (red). The blue diamond in the black square
is the estimated contact point with the VSMC where the AFM cantilever is in contact with the cell plasmamembrane and begins to bend. The blue line is the
Hertz fitting to the approach curve. (B) Representative retraction force curve recorded by AFM for pre-drug period (control). (C) Representative retraction
force curves after treatment with NO. (D) Representative retraction force curve after treatment with ANG II. The height between the paired red spots was
used to compute the adhesion force and the rupture number was used to evaluate the adhesion probability. The 1.5 fold of the average noise (signal
fluctuation) was set as the threshold of adhesion force and only the rupture force higher than threshold was considered as the real unbinding force between
cell membrane and AFM cantilever. The rupture indicated by two green spots was considered as noise and omitted in adhesion probability computation (C).
The snaps with low gap height were not the particular characteristics of the NO or ADO treated force curve, they also appeared in control and ANG II treated
force curve and were omitted as well.
doi:10.1371/journal.pone.0119533.g001
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membrane and AFM probe. The adhesion probability was computed as the number of effective
adhesion events per AFM retraction curve.
Statistical Analysis
Data are reported as the mean ± SEM. Statistically significant differences in the elasticity or ad-
hesion probability between the pre-drug controls and post-drug treatments were analyzed with
one way ANOVA. A value of P<0.05 was considered significant.
Results
VSMC E-modulus and adhesion probability increases in response to the
vasoconstrictor ANG II
Fig. 2 shows the alteration in E-modulus and adhesion probability of VSMC to the COL-I coat-
ed AFM probe upon ANG II stimulation. Following addition of ANG II to the cell bath the ad-
hesion probability (i.e. number of adhesion events per AFM retraction curve) to COL-I
progressively increased over a 30 min period as shown in a representative example of an indi-
vidual experiment (Fig. 2A) and for the entire group of cells (n = 10) tested (Fig. 2B, 2C). Dur-
ing the 10 min pre-drug control period the cell adhesion probability was approximately 2
events per curve and increased to approximately 3.1 events per curve 30 min post-exposure to
Fig 2. Continuous real-time recordings of E-modulus and adhesion probability of VSMC to COL-I coated AFM probe following stimulation with
ANG II. The adhesion probability is presented as the number of adhesion events per AFM retraction curve. (A) A representative individual example shows
the increase in VSMC adhesion probability after stimulation with ANG II. (B) Average adhesion probability before and after addition of ANG II for experimental
group (n = 10). (C) Average adhesion probability significantly increased after ANG II treatment. Data were summed over 1800 s and were presented as
mean ± SEM (n = 10, *P<0.05). (D) A representative single cell record of VSMC E-modulus shows the immediate increase in cell E-modulus after the
addition of ANG II in cell bath (10−6 M). (E) Alteration in group average of VSMC E-modulus before and after stimulation with ANG II (n = 10). (F) Average E-
modulus summed across all time points for the group significantly increased after addition of ANG II. Data were summed over 1800 s and were presented as
mean ± SEM (n = 10, *P<0.05.
doi:10.1371/journal.pone.0119533.g002
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ANG II stimulation. The averaged adhesion probability summed over the entire period of
ANG II exposure was significantly increased by*33% (Fig. 2C, n = 10, P<0.05). To confirm
the effect of ANG II on VSMC E-modulus was occurring in combination with the ANG II in-
duced increase in adhesion probability, cell E-modulus was estimated by fitting a modified
Hertz model to the AFM approaching force curve. As shown in a representative example of an
individual experiment (Fig. 2D), exposure to ANG II rapidly increased cell E-modulus from
*13.5 kPa to*18.5 kPa within 2 min and further increased to*22 kPa by 30 min. The
group average of E-modulus exhibited an increasing trend following exposure to ANG II
(Fig. 2E, n = 10). Fig. 2F shows the increase (*35%) in VSMC E-modulus averaged for the en-
tire group of experiments (n = 10, P<0.05).
No alteration in VSMC E-modulus or adhesion probability in sham
control experiment
To test if the cell adhesion or E-modulus were altered during the course of a repetitive indenta-
tion experiment, a sham control study was conducted with the addition of vehicle buffer to the
cell bath. Fig. 3A shows continuous real-time recordings of adhesion probability of VSMC to a
COL-I coated AFM probe in a representative sham control experiment. No significant alter-
ations were exhibited during the entire time course of the experiment. The group average adhe-
sion probability (Fig. 3B) and the average adhesion probability summed across all time points
before and after addition of vehicle buffer showed no significant alterations (Fig. 3C, n = 10,
P>0.05). The representative continuous real time measurement (Fig. 3D) and the group
Fig 3. Continuous real-time recordings of E-modulus and adhesion probability of VSMC to COL-I coated AFM probe in sham control experiments.
(A) A representative individual example shows no effect on adhesion probability after addition of vehicle buffer. (B) No change in adhesion probability was
shown in the group average adhesion probability before and after addition of vehicle buffer (n = 10). (C) Average adhesion probability summed across all time
points for the group of VSMCs before and after addition of vehicle buffer (n = 10, P>0.05). (D) A representative single cell measurement shows no changes in
E-modulus before and after addition of vehicle buffer in cell bath. (E)Group average VSMC E-modulus did not change before and after addition of vehicle
buffer in cell bath (n = 10). (F) No significant difference was shown in the average E-modulus summed for all time points before and after addition of vehicle
buffer (n = 10, P>0.05). Data were presented as mean ± SEM.
doi:10.1371/journal.pone.0119533.g003
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average (Fig. 3E) show the VSMCs’ E-modulus was approximately*12 kPa with no signifi-
cant alteration throughout the sham control experimental duration. Fig. 3F summarizes E-
modulus across all time points before and after addition of vehicle buffer to the cell bath (n =
10, P>0.05).
VSMC adhesion probability decreases in response to vasodilation by
ADO and NO
To determine if pharmacological vasodilation exerts opposite effects on VSMC adhesion be-
havior compared to ANG II, two potent vasodilators, ADO or NO were used to relax the
VSMC during the continuous AFM indentation cycles. Results showed that the adhesion prob-
ability of VSMC to COL-I significantly decreased following addition of ADO to the cell bath
from approximately 2 events per curve during the control period to 1.5 events per curve at 30
min post drug period as shown in a representative individual experiment (Fig. 4A). The group
average data confirmed the decrease in adhesion probability upon treatment with ADO
(Fig. 4B, n = 10). Average adhesion probability summed across all time points shows the re-
duction (−17%) in adhesion probability of VSMC to COL-I following ADO treatment (Fig. 4C
n = 10, P<0.05). The effect of the NO donor (PANOate) on the adhesion probability between
VSMC and COL-I is shown in a representative example (Fig. 4D). The adhesion probability
decreased rapidly after addition of NO donor to the cell bath. After 15 min stimulation with
Fig 4. Continuous real-time recordings of adhesion probability of VSMC to COL-I coated AFM probe following ADO or NO administration. (A) A
representative individual experiment shows the decrease in the adhesion probability after introduction of ADO in the cell bath. (B) Decrease in the group
average adhesion probability after addition of ADO in the cell bath (n = 10). (C) Average adhesion probability showed a significant decrease in adhesion
probability following addition of ADO. Data were summed over 1800 s and were presented as mean ± SEM (n = 10, *P<0.05). (D) NO donor dramatically
reduced adhesion probability as shown in a representative individual example. (E) Average adhesion events decreased after treatment with NO (n = 10). (F)
Average adhesion probability shows a significant decrease in adhesion probability after the addition of NO donor to the cell bath. Data were summed over
1800 s and were presented as mean ± SEM (n = 10, *P<0.05).
doi:10.1371/journal.pone.0119533.g004
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the NO donor adhesion was decreased to such an extent that significant adhesions were no lon-
ger detectable between VSMC and COL-I. The group average data showed the reduction trend
(Fig. 2E, n = 10) and a significant decrease (*33%) in the adhesion probability after stimula-
tion with NO (Fig. 2F, n = 10, P<0.05).
VSMC E-modulus decreases in response to vasodilation with ADO and
NO
The effects of the vasodilators ADO or NO on VSMC E-modulus are shown in Fig. 5. A re-
presentative example of a single cell record of VSMC E-modulus before and after addition
of ADO showed that the exposure to ADO lead to a significant decrease in cell E-modulus
from*13 kPa to*8 kPa (Fig. 5A). The group average of VSMC E-modulus confirmed the
decrease in cell E-modulus upon exposure to ADO (Fig. 5B, n = 10). Average E-modulus
summed across all time points for the group of VSMCs before and after addition of ADO also
demonstrated a significant decrease by −31% (Fig. 5C, n = 10, P<0.05). Compared to ADO,
the NO donor had a more pronounced effect on cell E-modulus, in a representative experimen-
tal example, NO reduced cell stiffness to barely detectable levels indicative of a loss of cortical
stiffness (Fig. 5D). The group average of VSMC E-modulus alteration before and after addition
of NO in the cell bath confirmed the decreasing trend in cell E-modulus following NO treat-
ment (Fig. 5E, n = 10). Fig. 5F presents the significant decrease (−38%) in the average E-mod-
ulus summed over the entire period of NO exposure (n = 10, P<0.05).
Fig 5. Continuous real-time VSMC E-modulus recordings following ADO or NO. (A) VSMC E-modulus immediately reduced after addition of ADO
(10−4 M) as shown in a representative example. (B)Group average of VSMC E-modulus after addition of ADO (n = 10) in cell bath. (C) Average E-modulus
summed across all time points for the group of VSMCs before and after ADO (n = 10, *P<0.05). (D) A representative single cell measurement shows
decrease in VSMC E-modulus following addition of NO to the cell bath. (E) Alteration in group average of VSMC E-modulus before and after addition of NO
(n = 10). (F) Average E-modulus summed for all time points before and after addition of NO showed a significant decrease in VSMC E-modulus (n = 10,
*P<0.05). Data were presented as mean ± SEM.
doi:10.1371/journal.pone.0119533.g005
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Discussion
VSMCs within the walls of arteries sense, transduce, and generate mechanical forces. They de-
tect both local and soluble vasoactive signals and respond by alterations in vascular smooth
muscle tone that is fundamental to regulation of vessel diameter. Integrin-mediated cell adhe-
sion to ECM at focal adhesion sites has been identified as one major mechanosensory site as
well as an important region for transmission of mechanical forces and cell signals [20,23]. Of
relevance to our hypothesis, the integrins maintain the integrity of cell adhesion and act as logi-
cal sites for transmission of force from the external environment to the cytoskeleton and for
transmission of generated cellular contractile force to ECM. In our previous studies, we dem-
onstrated that adhesion between VSMCs and the ECM protein FN was regulated by vasoactive
agonists [4,28]. The vasoconstrictor ANG II up-regulated cell adhesion to FN and induced a
significant increase in cell E-modulus. In addition, ANG II increased the density and orienta-
tion of actin stress fibers in the VSMC cell cortex. In contrast, the vasodilator ADO down-regu-
lated cell adhesion, cell E-modulus, and reduced the density and orientation of the actin stress
fibers in the cell cortex. Our findings in the present study are consistent with these observations
as applied to COL-I and further support the concept that ECM adhesion in VSMC is regulated
in tandem with changes in VSMC contractile activation.
The current study employed AFM for real time monitoring of cell E-modulus and adhesion
similar to our prior VSMC-FN study [4]. Cellular E-modulus was evaluated by AFM with a
well established method [29]. 100–300 nm depth of cell cortex was indented with 5μm spheri-
cal AFM probe and a modified Hertz model was fitted to the approaching force curve since cell
cortex is normally around 300 nm thickness [30]. Our results clearly indicate that ANG II sig-
nificantly increases both VSMC adhesion probability to COL-I and VSMC E-modulus, where-
as ADO and NO decrease adhesion to COL-I and E-modulus of VSMCs. Our results suggest
the integrin-mediated interaction between the ECM and VSMC is modulated by G-protein
coupled receptor signaling that is also linked to activation of the contractile machinery of the
cell. Thus, there appears to be a receptor dependent inside-out pathway for modulation of ad-
hesion during VSMC activation.
The alterations in VSMC adhesion to COL-I and FN [4] following treatment with vasoactive
agents (constrictor and dilator) may function as a means of tuning adhesion to cellular force
generation. As such, when the VSMC is generating force, the focal adhesion sites adhere more
tightly and become more efficient sites for force transmission. Likewise when force generation
declines this is accompanied by decreased adhesion. In addition, this increase in adhesion
would be anticipated to augment outside-in signaling through VSMC focal adhesions [31–33].
The changes in cell E-modulus following treatment with ANG II, ADO or NO are consistent
with rapid remodeling in the cortical actin cytoskeleton as we have previously shown [28]. This
compartment of actin is generally considered as non-contractile, and has been demonstrated to
rapidly remodel during activation of smooth muscle contraction and is required for full devel-
opment of a VSMC contractile event. It is noteworthy that the effects of adenosine were less
pronounced than those of NO. This is consistent with NO being a more potent vasodilator
than adenosine. In addition, NOmay act more rapidly because it does not act through a G-pro-
tein coupled receptor, as does adenosine. The ability of NO to directly activate cyclic GMP as
opposed to receptor-mediated activation of cyclic AMP by adenosine could also accounts for
differences in rate and magnitude over the time course studied.
Consistent with our findings in VSMC, Gunst et al. have previously reported that dynamic
cytoskeletal changes occur during contraction of pulmonary smooth muscle cells. They report
that a non-contractile actin compartment of the cytoskeleton was actively involved in deter-
mining development of contractile tone and those changes in actin binding proteins and focal
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adhesion proteins are an orchestrated component of airway smooth muscle cell contraction
[34–36]. Similarly, Morgan et al. have also reported that actin cytoskeleton remodeling [37]
and reorganization occurs within cell cortex and the focal adhesion complex during contrac-
tion of VSMC [38–39]. More recently, a similar reorganization in cytoskeletal structure during
myogenic constriction of cerebral arteries was reported [40]. Collectively, these findings sup-
port the general concept that cell contraction in smooth muscle is strongly coupled to changes
in cell adhesion, focal adhesion proteins and cell stiffness due to cortical cytoskeletal remodel-
ing of the submembranous actin compartment.
In our study we used isolated VSMCs and maintained them in primary culture without pas-
sage to minimize any phenotypic changes. The use of our AFM protocol required that the
VSMCs firmly attach to the substrate and the short-term primary culture allows for this period
of attachment as well as recovery from the enzymatic effects of the isolation process. Ultimate-
ly, measurement of cell adhesion and E-modulus of VSMCs in their native environment would
be ideal but with the AFM this is still technically not achievable.
In summary, our results showed that the vasoconstrictor ANG II increased both VSMC E-
modulus and the probability of cell adhesion to COL-I. In contrast, the vasodilators ADO or
the NO donor PANOate decreased VSMC E-modulus and reduced COL-I adhesion probabili-
ty. These observations support our hypothesis that integrin-mediated VSMC adhesion to the
ECM protein COL-I is dynamically regulated in parallel with the VSMC contractile activation.
This supports a strong association between the signal transduction pathways involved in cell
contraction and cell adhesion. Obviously, additional work is required to identify the molecular
mechanisms underlying the coupling of VSMC adhesion and E-modulus, and to determine
whether these pathways are parallel or share similar intermediate steps. It is of interest that in
aging and hypertension, both cell stiffness and adhesion of VSMC from the aorta are signifi-
cantly enhanced [18–19]. Thus, identifying these mechanisms may help to provide valuable
clues in cardiovascular disease relating to the cause of vascular stiffness, thereby, assisting in
developing novel treatment strategies.
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